Incidence of Post-intravitreal Anti-VEGF Endophthalmitis at Thammasat University Hospital
Not Applicable
Completed
- Conditions
- all consecutive eyes after intravitreal injections was performed at the Thammasat University Hospitalendophthalmitis,anti VEGF drug,intravitreal injection,ranibizumab,bevacizumab
- Registration Number
- TCTR20141119002
- Lead Sponsor
- faculty of Medicine, Thammasat University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1167
Inclusion Criteria
patient with endophthalmitis secondary to therapeutic intravitreal ranibizumab and bevacizumab injections
Exclusion Criteria
unreliable medical record
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method